ID: ALA193491

Max Phase: Preclinical

Molecular Formula: C19H14N2O4

Molecular Weight: 334.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ncccc1C(=O)O)c1cccc(Oc2ccccc2)c1

Standard InChI:  InChI=1S/C19H14N2O4/c22-18(21-17-16(19(23)24)10-5-11-20-17)13-6-4-9-15(12-13)25-14-7-2-1-3-8-14/h1-12H,(H,23,24)(H,20,21,22)

Standard InChI Key:  JJMTWSTZUQZFEA-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-ketoacyl-ACP synthase III 89 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 334.33Molecular Weight (Monoisotopic): 334.0954AlogP: 3.82#Rotatable Bonds: 5
Polar Surface Area: 88.52Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.93CX Basic pKa: 1.11CX LogP: 4.25CX LogD: 1.05
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.74Np Likeness Score: -1.09

References

1. Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S..  (2005)  Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.,  48  (5): [PMID:15743201] [10.1021/jm049141s]

Source